Recent

% | $
Quotes you view appear here for quick access.

NPS Pharmaceuticals, Inc. Message Board

  • faosto faosto Oct 16, 2013 5:11 PM Flag

    OT- Going forward, what's your second best biotech pick?

    For the believers in NPSP who know that this is headed to $45+, I'm curious what biotech pick you would put up as second or third choice to this? Mine right now would have to be either KERX or RMTI. Possibly PCYC. I own all of them. Anyone believe in NLNK?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I have RMTI and NPSP oJust recently bought NSPR on a dump during the shutdown I really like this one. APPY has been good. Atrs looking nice with FDA approval and hasn't popped just yet..

    • Ml_expert, Magic 9z9, and EyesandEars51 have all provided good picks and thoughtful advise. I will add PCYC to the mix.

    • My second best bet is RMTI, third one is SRPT. KERX is too risky given the patent concerns. NLNK seems like an old story. There is a nice bear story about it at Motley Fool.

      Sentiment: Strong Buy

    • I have KYTH. Market cap less than a billion and big potential in top drug. Should file NDA by end of Q1.

    • On October 14, I posted, “ last week I sold my considerable position in NPSP, to lock in a large profit, and replaced the stock with November 16 options.” Options offered two advantages:

      1- Protecting against a choppy market. Even after today’s impressive 8.63% rebound, NPSP is still 13% lower than the $ 34.98 October 7 close.

      2- The leveraged options value has increased more than the underlying stock today.

      I also indicated that, “ Based on the charts, I will re-enter the stock at four different price levels between $ 22 and $ 27…….. The strategy changes if the broader market, and IBB decisively rebound, precipitated by a resolution to the debt/budget crisis. “

      Where do we go from here? We know the following: External events were a major contributor to NPSP’s 20+% correction; The next known catalyst, is the November 4 earnings report. The question to be resolved, is today’s large pop a one day relief rally or will it continue through November 4. The movement and trading volume of NPSP, the IBB ETF, and S&P Thursday and Friday will provide the answer. Three consecutive days in either direction, usually confirms a rally or correction.

      Some other high beta biotech’s rallying today to watch: REGN, up 5.8%, EXAS, up 5.7%, ARRY, up 4.97%, SRPT up 4.63%.

 
NPSP
0.00(0.00%)